Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
TORONTO, Dec. 17 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today its results for the...
TORONTO, Dec. 2 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that it will report its...
TORONTO, Dec. 1 /CNW/ - Patheon (TSX: PTI) announced today that Wesley P. Wheeler has left the company. Mr. Wheeler was Patheon's Chief Executive Officer and President. Ramsey Frank, Patheon's...
TORONTO, Sept. 9 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today its results for the...
TORONTO, Aug. 6 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that it will report its...
TORONTO, June 11 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today its results for the...
Patheon designated as a 'preferred supplier' to Merck RESEARCH TRIANGLE PARK, NC, June 10 /CNW/ - Patheon (TSX: PTI), a global provider of drug development and manufacturing services to the...
TORONTO, May 27 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that it will report its...
RESEARCH TRIANGLE PARK, NC, May 4 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that its...
RESEARCH TRIANGLE PARK, N.C., April 29 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry invites customers,...
TORONTO, April 26 /CNW/ - Patheon Inc. (TSX:PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced today the completion of its...
TORONTO, April 15 /CNW/ - Patheon, Inc. (TSX: PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that Mark Kontny,...
Names industry veteran Edgar Jaynes, Ph.D. to lead the unit. RESEARCH TRIANGLE PARK, N.C., April 13 /CNW/ - Patheon (TSX: PTI), a global provider of drug development and manufacturing services to the ...
RESEARCH TRIANGLE PARK, N.C., April 9 /CNW/ - Patheon Inc. (TSX: PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced today...
RESEARCH TRIANGLE PARK, NC, April 5 /CNW/ - Patheon Inc. (TSX: PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced today...
Outsourcing activity beginning to show positive signs of improvement TORONTO, March 15 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international ...
TORONTO, March 8 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that it will report its...
TORONTO, Feb. 1 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it will present at the...
RESEARCH TRIANGLE PARK, NC, Jan. 21 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today it has...
TORONTO, Jan. 20 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it will present at the...
Agreements extend long standing manufacturing partnership between the companies TORONTO, Jan. 11 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the...
TORONTO, Jan. 5 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it will present at the...
Operating income increases in the quarter and for the year on lower revenues. TORONTO, Dec. 18 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the...
Product is the first FDA approved pre-filled subcutaneous, needle-free delivery system for use in the U.S. TORONTO, Dec. 15 /CNW/ - Patheon (TSX: PTI) a global provider of drug development and...
Shareholder withdraws meeting requisition. ------------------------------------------ TORONTO, Dec. 11 /CNW/ - Shareholders of Patheon Inc. (TSX:PTI) are advised that the Special Meeting of ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.